Miller et al. investigated the immunomodulatory activity programs of glioma-associated myeloid cells by co-culturing GBOs with human myeloid CD11b and CD45-positive cells, isolated from tumour or donor patient peripheral blood mononuclear cells (PBMCs). The gene discussed is PTPRC; the disease is central nervous system cancer.